CN1CCc2cc(O)c3cc2C1Cc1ccc(cc1)Oc1cc(ccc1O)CC1c2c(cc4c(c2O3)OCO4)CCN1C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?